We have reported previously that withaferin A (WA) prevents breast cancer development in mouse mammary tumor virus-neu (MMTV-neu) transgenic mice, but the mechanism is not fully understood. Unbiased proteomics of the mammary tumors 
Indian ginseng belonging to the Solanaceae family of flowering plants, is used quite heavily in Ayurvedic medicine formulations. 11 Anticancer effect of this plant is attributable to steroidal lactones including withaferin A (WA), 12-deoxywithastramonolide, withanone, withanolide A, and so forth. 11, 12 Cellular studies have revealed a much greater sensitivity of breast cancer cells to growth inhibition by WA when compared to withanone or withanolide A. 13 Cancer chemopreventive effect of WA has been demonstrated in preclinical rodent models of breast and other cancers. [14] [15] [16] [17] For example, the incidence of 7,12-dimethylbenz[a]anthracene-induced oral cancer in hamsters was completely inhibited by oral administration of 20 mg WA/kg body for 14 weeks. 14 Oral administration of WA (3 and 5 mg/kg body weight) was also effective for prevention of prostate cancer development in a transgenic mouse model. 15 Experimental evidence for chemopreventive efficacy of WA against breast cancer was provided by our research group. 16, 17 We were the first to demonstrate in vivo efficacy of WA for chemoprevention of human epidermal growth factor receptor 2-driven estrogen receptor-negative breast cancer using mouse mammary tumor virus-neu (MMTV-neu) transgenic mouse model. 16 In this study, macroscopic mammary tumor size, microscopic mammary tumor area, and the incidence of pulmonary metastasis were significantly lower in MMTV-neu mice after 28 weeks of treatment with WA (∼4 mg/kg body weight intraperitoneally, three times/week) compared with controls. 16 In a follow-up study, we reported prevention of N-methyl-N-nitrosourea (MNU)-induced luminal-type (estrogen receptor-positive) breast cancer in rats by WA administration. 17 Consistent with in vitro data, breast cancer chemoprevention by WA treatment in MMTV-neu mice as well as in the rat model was associated with reduced cell proliferation, increased apoptosis, and inhibition of breast cancer stem cell-like population. [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] We showed previously that breast cancer prevention by WA in MMTV-neu mice was associated with a decrease in protein levels of peptidyl-prolyl cis/trans isomerase (Pin1) through unbiased proteomics. 16 The Pin1 protein, which plays an important role in mammary gland development as well as in various steps of breast cancer progression, catalyzes cis/trans isomerization of phospho-Ser/Thr-Pro motifs in many proteins. [27] [28] [29] Because Pin1 controls isomerization of numerous cancerrelevant proteins, it is considered a valid therapeutic target. 28, 29 The present study was undertaken to determine the functional significance of Pin1 in chemopreventive mechanisms of WA in breast cancer.
| MATERIALS AND METHODS

| Reagents
Withaferin A (WA, purity >95%) was purchased from ChromaDex (Irvine, CA) and dissolved in dimethyl sulfoxide (DMSO were selected in the presence of 1 mg/mL of G418 for 2 months.
| Immunohistochemistry
Immunohistochemistry for Pin1 protein in tumor sections of control-and WA-treated MMTV-neu mice was performed as described by us previously for other proteins. 16, 17 Immunohistochemical images were analyzed using the Aperio ImageScope software which provides quantitative assessment of immunohistochemical staining with specified algorithm-based scoring method. Quantitative results are expressed as H-score. The H-score is a widely accepted method for quantitation of immunohistochemical data.
The H-score is based on intensity (0, 1+, 2+, and 3+) and % positivity (0-100%) and calculated using the formula: H-score = (% negative cells × 0) + (% 1+ cells × 1) + (% 2+ cells × 2) + (% 3+ cells × 3). 16 
| Western blot analysis
Details of tumor supernatant preparation for immunoblotting have been described by us previously. 16 Cells (5 × 10 5 cells per dish) were seeded in 6-cm dishes, allowed to attach, and then exposed to DMSO or the indicated dose(s) of WA for specified time period. Details of cell lysate preparation and Western blotting have been described by us previously. 31 Membranes were stripped and re-probed with anti-GAPDH or anti-β-Actin antibody to correct for difference in protein loading. Proteins of interest were quantitated by using UN-SCAN-IT gel automated digitizing system (Version 5.1, Silk Scientific, Orem, UT). 
| Confocal microscopy
| Apoptosis detection
Apoptosis was measured by the Annexin V/propidium iodide method. 
| Molecular docking
Molecular docking was done using Hex8.0 software (http://hex.loria. fr). The structure used for docking was from Protein Data Base (PDB ID for human Pin1 3TBD) with resolution 2.27Å. Output of the docking was analyzed using Discovery Studio Client 3.5 software.
| Mass spectrometric analysis of interaction of WA with Pin1
Recombinant human Pin1 protein was dialyzed in phosphate-buffered saline for 2 h to remove dithiothreitol. Subsequently, 2.5 μg of Pin1 protein was suspended in phosphate-buffered saline and incubated with 10 μM of WA or DMSO (control) for 4 h at 37°C. Protein sample was reduced/ alkylated, precipitated, re-suspended in 100 mM triethyl ammonium bicarbonate buffer, and digested overnight with proteomic grade trypsin.
The digested samples were loaded on an SCX column and eluted with 150 and 450 mM of ammonium acetate. The fractions were dried down in a speed-vac and suspended in 0.1% formic acid. Prior to liquid chromatography-tandem mass spectrometry (LC-MS/MS), peptides was desalted, dried in a speed-vac, and reconstituted in a solution containing 2% acetonitrile and 0.1% formic acid. For LC-MS/MS, each sample was loaded onto at C18 column (New Objective, Woburn, MA) using a Thermo Scientific Surveyor
Auto-sampler operating in the no-waste injection mode. Peptides were eluted from the column using a linear acetonitrile gradient from 2 to 30% acetonitrile over 150 min followed by high and low organic washes for another 30 min using an LTQ XL mass spectrometer via a nanospray source 
| Statistical analysis
Unpaired student's t-test was used for two sample comparisons. One-way analysis of variance (ANOVA) followed by Bonferroni's test was used for multiple comparison. Difference was considered significant at P < 0.05.
Statistical analyses were performed using GraphPad Prism 7.02 (La Jolla, CA).
3 | RESULTS
| WA administration decreased Pin1 protein expression
Initially we used mammary tumor sections from control-and WA-treated (structure of WA is shown in Figure 1A ) MMTV-neu mice to confirm the proteomics data showing downregulation of Pin1 by WA administration. 16 Representative microscopic images depicting expression of Pin1 protein in mammary tumor sections of control-and WA-treated MMTVneu mice are shown in Figure 1B . Protein level of Pin1 was modestly but statistically significantly lower in the mammary tumor sections of WAtreated mice compared with control ( Figure 1C ). We also used tumor supernatants from control-and WA-treated rats 17 to determine Pin1 expression by Western blotting ( Figure 1D ). Level of Pin1 protein was lower by about 55% in breast tumors of WA-treated rats when compared to that of controls ( Figure 1E ) but the difference did not reach statistical significance due to large data scatter and small sample size (n = 6).
Nevertheless, these results indicated downregulation of Pin1 protein in breast tumors by WA administration in mice and rats.
3.2 | Pin1 regulated cell cycle arrest by WA treatment Combined results from two experiments are shown as mean ± SD (n = 5 ∼ 6). Effect of myc-Pin1 overexpression on WA-mediated (24 h treatment) (G) mitotic arrest and (H) total apoptosis in SK-BR-3 cells. Experiments were done at least twice with consistent results and representative data from one such experiment are shown as mean ± SD (n = 3). Statistically significant (P < 0.05) compared with the *corresponding DMSO-treated control or # between pcDNA3 and myc-Pin1 groups by one-way ANOVA followed by Bonferroni's multiple comparison test be related to differences in expression levels of other proteins implicated in apoptotic cell death regulation.
| Pin1 overexpression attenuated Cyclin B1 stabilization by WA treatment in MCF-7 cells
We have shown previously that WA-mediated cell cycle arrest in MCF-7 cells is associated with stabilization of Cyclin B1 level but downregulation of Cdc25C, Cdc2, and β-Tubulin proteins. show antibody array data for other apoptosis regulating proteins.
Interestingly, IGF-I, IGF-II, and IGF-1sR levels were also increased upon WA treatment in Pin1 overexpressing MCF-7 cells when compared to empty vector transfected control cells ( Figure 7C ). These results suggest 
| DISCUSSION
The present study shows downregulation of Pin1 by WA treatment in breast cancer cells. Overexpression of Pin1 protein in breast cancer is associated with poor clinical outcome. 29, 34, 35 Pin1 plays an important role in normal mammary development as well as in breast cancer progression by regulating stability or activity of numerous proteins. 29 Some of the targets of Pin1 (eg, estrogen receptor-α, STAT3, NF-κB, Notch-1) are also downregulated by WA treatment. For example, the Pin1 binding motif in STAT3 is Ser727, which promotes its transcriptional activity. 36 We have shown previously that WA treatment inhibits constitutive as well as interleukin-6-inducible -WA adduct activation of STAT3 in breast cancer cells. 21 We also showed that WA-mediated inhibition of STAT3 activation was accompanied by suppression of Tyr705 and Ser727 phosphorylation and its dimerization. 21 It is possible that WA treatment inhibits Ser727 phosphorylation of STAT3 in a Pin1-dependent manner. Likewise, we have shown previously that WA downregulates expression of estrogen receptor-α, 23 which is another target of Pin1. Pin1 was shown to regulate N-terminal conformation and function of estrogen receptor-α. 37 Another study showed a role for Pin1 in regulation of estrogen receptor-α level through phosphorylation-dependent ubiquitination and degradation. 38 These examples illustrate that some effects of WA in breast cancer cells may be mediated by Pin1.
WA treatment causes arrest of breast cancer cells in G 2 and mitotic phases of the cell cycle, which is not a cell line-specific phenomenon. 13, 19 It was shown previously that Pin1 depletion in yeast 
